IP Verse
Top Law Firms
Unified Patent Court
Trending Technologies
Blogs
Contact Us
Toggle menu
Birdie Biopharmaceuticals Inc. opposition analysis
COMPANY ANALYSIS
Latest patents of Birdie Biopharmaceuticals Inc. opposed by its competitors
Patent:
EP3166976
Grant Date:
Feb 23, 2022
Title:
Anti-Pd-L1 Combinations For Treating Tumors
Oppositions:
1
Latest patents of Birdie Biopharmaceuticals Inc. opposed by its competitors
Patent Number
Grant Date
Title
Total Oppositions
EP3166976
Feb 23, 2022
Anti-Pd-L1 Combinations For Treating Tumors
1
Competitors of Birdie Biopharmaceuticals Inc.
PATENT BOUTIQUE LLP
Want to track Birdie Biopharmaceuticals Inc.?
Feel free to send us a message here and we will get back to you
Name
Email
Message
Let's get in touch